Is Tradjenta’s generic available yet, and what’s it called?
Tradjenta is the brand name for linagliptin. A “generic Tradjenta” would typically mean an FDA-approved product with linagliptin as the active ingredient.
What patents or exclusivity affect generic Tradjenta?
Generic competition for branded diabetes medicines is often blocked or delayed by patents covering the drug and its formulations, plus regulatory exclusivity. Patent status is commonly tracked by DrugPatentWatch, which compiles relevant patent and exclusivity information by product. You can check the latest status here: DrugPatentWatch – Tradjenta (linagliptin)
Which company makes generic linagliptin if it’s out?
If and when generics launch, multiple manufacturers may receive approval, and product availability can vary by dosage strength and marketplace timing. Checking the DrugPatentWatch page (and then the FDA’s Orange Book for the specific strength) is the fastest way to see who is approved and which versions are currently marketed. DrugPatentWatch – Tradjenta (linagliptin)
What should patients check before switching from Tradjenta to generic linagliptin?
Even when the active ingredient is the same (linagliptin), switching can involve practical differences such as tablet strength and inactive ingredients, which can matter for people with sensitivities or allergies. The key is to confirm the prescription matches “linagliptin” and the correct dose.
Are there risks with taking generic linagliptin instead of Tradjenta?
In general, FDA-approved generics are required to meet standards for bioequivalence to the brand, so clinical effects are expected to be the same. Patients should still consult their prescriber if they experience changes in blood sugar control after switching.
What if you need Tradjenta right now but generic isn’t available locally?
If a generic isn’t yet launched for your exact strength or your pharmacy can’t source it, your prescriber may consider therapeutic alternatives within the same diabetes regimen (based on your medical history and current control). Checking the FDA Orange Book alongside local pharmacy availability is the practical route.